Vaxcyte Income from Continuous Operations 2019-2024 | PCVX
Vaxcyte income from continuous operations for the twelve months ending September 30, 2024 was $-0.508B, a 69.49% increase year-over-year.
- Vaxcyte annual income from continuous operations for 2023 was $-0.402B, a 80% increase from 2022.
- Vaxcyte annual income from continuous operations for 2022 was $-0.223B, a 123.31% increase from 2021.
- Vaxcyte annual income from continuous operations for 2021 was $-0.1B, a 12.17% increase from 2020.